-
2
-
-
70849116358
-
Profiling critical cancer gene mutations in clinical tumor samples
-
MacConaill LE, Campbell CD, Kehoe SM, et al. Profiling critical cancer gene mutations in clinical tumor samples. PloS One. 2009;4(11):e7887.
-
(2009)
PloS One.
, vol.4
, Issue.11
, pp. e7887
-
-
MacConaill, L.E.1
Campbell, C.D.2
Kehoe, S.M.3
-
3
-
-
84880473776
-
Personalizing oncology: Perspectives and prospects
-
Mendelsohn J. Personalizing oncology: perspectives and prospects. J Clin Oncol. 2013;31(15):1904-1911.
-
(2013)
J Clin Oncol.
, vol.31
, Issue.15
, pp. 1904-1911
-
-
Mendelsohn, J.1
-
4
-
-
84903522671
-
Implementing personalized cancer care
-
Schilsky RL. Implementing personalized cancer care. Nat Rev Clin Oncol. 2014;11(7):432-438.
-
(2014)
Nat Rev Clin Oncol.
, vol.11
, Issue.7
, pp. 432-438
-
-
Schilsky, R.L.1
-
5
-
-
84941962196
-
Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial
-
Chantrill LA, Nagrial AM, Watson C, et al. Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial. Clin Cancer Res. 2015;21(9):2029-2037.
-
(2015)
Clin Cancer Res.
, vol.21
, Issue.9
, pp. 2029-2037
-
-
Chantrill, L.A.1
Nagrial, A.M.2
Watson, C.3
-
6
-
-
84901936604
-
Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next-Generation Sequencing Panel
-
Johnson DB, Dahlman KH, Knol J, et al. Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next-Generation Sequencing Panel. Oncologist. 2014;19(6):616-622.
-
(2014)
Oncologist.
, vol.19
, Issue.6
, pp. 616-622
-
-
Johnson, D.B.1
Dahlman, K.H.2
Knol, J.3
-
7
-
-
84901918076
-
Molecular tumor board: The university of California san diego moores cancer center experience
-
Schwaederle M, Parker BA, Schwab RB, et al. Molecular Tumor Board: The University of California San Diego Moores Cancer Center Experience. Oncologist. 2014;19(6):631-636.
-
(2014)
Oncologist.
, vol.19
, Issue.6
, pp. 631-636
-
-
Schwaederle, M.1
Parker, B.A.2
Schwab, R.B.3
-
8
-
-
84900829967
-
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs
-
Kris MG, Johnson BE, Berry LD, et al. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. JAMA. 2014;311(19):1998-2006.
-
(2014)
JAMA.
, vol.311
, Issue.19
, pp. 1998-2006
-
-
Kris, M.G.1
Johnson, B.E.2
Berry, L.D.3
-
9
-
-
84941361474
-
Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment onto Genomically Matched Clinical Trials
-
Meric-Bernstam F, Brusco L, Shaw K, et al. Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials. J Clin Oncol. 2015;33(25):2753-2762.
-
(2015)
J Clin Oncol.
, vol.33
, Issue.25
, pp. 2753-2762
-
-
Meric-Bernstam, F.1
Brusco, L.2
Shaw, K.3
-
10
-
-
57849117384
-
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
-
Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228-247.
-
(2009)
Eur J Cancer.
, vol.45
, Issue.2
, pp. 228-247
-
-
Eisenhauer, E.A.1
Therasse, P.2
Bogaerts, J.3
-
11
-
-
84887491073
-
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
-
Frampton GM, Fichtenholtz A, Otto GA, et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol. 2013;31(11):1023-1031.
-
(2013)
Nat Biotechnol.
, vol.31
, Issue.11
, pp. 1023-1031
-
-
Frampton, G.M.1
Fichtenholtz, A.2
Otto, G.A.3
-
12
-
-
84896730857
-
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: A multicentre, prospective trial (SAFIR01/UNICANCER)
-
Andre F, Bachelot T, Commo F, et al. Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER). Lancet Oncol. 2014;15(3):267-274.
-
(2014)
Lancet Oncol.
, vol.15
, Issue.3
, pp. 267-274
-
-
Andre, F.1
Bachelot, T.2
Commo, F.3
-
13
-
-
84904108521
-
Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: Results of the feasibility part of the SHIVA trial
-
Le Tourneau C, Paoletti X, Servant N, et al. Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial. Br J Cancer. 2014;111(1):17-24.
-
(2014)
Br J Cancer.
, vol.111
, Issue.1
, pp. 17-24
-
-
Le Tourneau, C.1
Paoletti, X.2
Servant, N.3
-
14
-
-
84938209813
-
A decision support framework for genomically informed investigational cancer therapy
-
Meric-Bernstam F, Johnson A, Holla V, et al. A decision support framework for genomically informed investigational cancer therapy. J Natl Cancer Inst. 2015;107(7):djv098 doi:10.1093/jnci/djv098.
-
(2015)
J Natl Cancer Inst.
, vol.107
, Issue.7
, pp. djv098
-
-
Meric-Bernstam, F.1
Johnson, A.2
Holla, V.3
-
15
-
-
84902674966
-
Correlation of somatic mutations and clinical outcome in melanoma patients treated with carboplatin, paclitaxel, and sorafenib
-
Wilson MA, Zhao F, Letrero R, et al. Correlation of somatic mutations and clinical outcome in melanoma patients treated with carboplatin, paclitaxel, and sorafenib. Clin Cancer Res. 2014;20(12):3328-3337.
-
(2014)
Clin Cancer Res.
, vol.20
, Issue.12
, pp. 3328-3337
-
-
Wilson, M.A.1
Zhao, F.2
Letrero, R.3
|